-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QaUUWPa1/jhnkWKr0LoCRo5bJzkI1afmsBrd6RxJEFcadTNKJ/zgjTQHD6VobX8Q GrPtqws9OxoZKWJJO/SMkg== 0001144204-11-005015.txt : 20110131 0001144204-11-005015.hdr.sgml : 20110131 20110131171045 ACCESSION NUMBER: 0001144204-11-005015 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110131 DATE AS OF CHANGE: 20110131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: China Yongxin Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001087848 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 880420306 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-167416 FILM NUMBER: 11560351 BUSINESS ADDRESS: STREET 1: 927 CANADA CT. CITY: CITY OF INDUSTRY STATE: CA ZIP: 91748 BUSINESS PHONE: 626-581-9098 MAIL ADDRESS: STREET 1: 927 CANADA CT. CITY: CITY OF INDUSTRY STATE: CA ZIP: 91748 FORMER COMPANY: FORMER CONFORMED NAME: Nutradyne Group, Inc. DATE OF NAME CHANGE: 20080124 FORMER COMPANY: FORMER CONFORMED NAME: Nutradyne, Inc. DATE OF NAME CHANGE: 20071105 FORMER COMPANY: FORMER CONFORMED NAME: Digital Learning Management CO DATE OF NAME CHANGE: 20060802 RW 1 v209592_rw.htm Unassociated Document
CHINA YONXIN PHARMACEUTICALS INC.
927 Canada Court
City of Industry, California 91748

January 31, 2011

Via EDGAR

Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington D.C., 20549
 
  Re:
China Yongxin Pharmaceuticals Inc.
Request to Withdraw Registration Statement
Registration No. 333-167416
 
Ladies and Gentlemen:

Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), China Yongxin Pharmaceuticals Inc. (the “Company”) hereby respectfully requests the withdrawal of its registration statement on Form S-1, initially filed on June 9, 2010 (the “Registration Statement”).

No securities have been issued or sold under the Registration Statement.  The reason for this withdrawal is that, in light of current market conditions, the Company has decided not to pursue the public offering of its common stock described in the Registration Statement.  The Company also requests, in accordance with Rule 457(p) of the Securities Act, that all fees paid to the Securities and Exchange Commission in connection with the filing of the Registration Statement be credited for future use.

Please contact the Company’s legal counsel, Nimish Patel at Richardson & Patel LLP at (310) 208-1182, if you have any questions.

Thank you for your assistance in this matter.
 
     
    Very truly yours,  
       
    CHINA YONGXIN PHARMACEUTICALS INC.  
       
 
 
 /s/ Yongxin Liu  
    Yongxin Liu  
   
Chief Executive Officer
  
       
-----END PRIVACY-ENHANCED MESSAGE-----